Boehringer Ingelheim, MD Anderson to jointly advance new cancer therapies
This article was originally published here
In this regard, Boehringer Ingelheim and MD Anderson plan to set up a joint Virtual Research and Development Center to facilitate effective data sharing and analysis among themselves.
The post Boehringer Ingelheim, MD Anderson to jointly advance new cancer therapies appeared first on Pharmaceutical Business review.
Leave a Reply
Want to join the discussion?Feel free to contribute!